Emma Walmsley, GSK’s CEO, will be replaced by Luke Miels, the chief commercial officer, after almost nine years in the role. Miels has been with GSK since 2017 and has led global medicines and vaccine efforts. The change is effective January 1.

GSK Plc Chief Executive Officer Emma Walmsley is stepping down after almost nine years and will be succeeded by the British drugmakers chief commercial officer, Luke Miels.
Also Read: UK investigate…